Cilcare Secures Funding to Advance Clinical Trials for Cochlear Synaptopathy Treatment
Cilcare raised €40 million in Series A funding to initiate two clinical trials in 2025 for treatment of cochlear synaptopathy.
Read More
Search Results for: synaptopathy
Cochlear Synaptopathy and Speech-in-Noise Problems Linked
Researchers have linked difficulty understanding speech in noisy environments with evidence of cochlear synaptopathy, or “hidden hearing loss,” in college students with normal hearing sensitivity.
Read More
Cilcare Study to Explore Hearing in Patients with Neurodegenerative Diseases
The study aims to develop auditory biomarkers for early detection and improved management of Alzheimer’s and Parkinson’s disease.
Read More
Cilcare Names New Chief Medical Officer
Cilcare appointed Bettina Cockroft as its new CMO who will leverage years of expertise in clinical development and biopharma innovation.
Read More
France Awards Cilcare Funding to Combat Hidden Hearing Loss
Cilcare’s SAIPHIE project has been selected for the “i-Démo” call for projects under the France 2030 plan, aiming to leverage their expertise to address synaptopathy
Read More
Cilcare and Shionogi Announce Option Agreement for Hearing Disorder Treatment
Cilcare granted the pharmaceutical company rights to license two promising drug candidates for hearing disorders.
Read More
Cilcare Names New Chief Medical Officer
Cilcare has appointed a new chief medical officer to oversee clinical development strategies and collaborations, leveraging his extensive experience in medical affairs and pharmaceutical industry leadership.
Read More
Hearing Protection Program for Dental Students: The Journey
Musician earplugs and hearing health education can benefit professionals in other industries, like dentistry, who suffer from hearing loss.
Read More
Using the ACT Test for Speech-in-Noise Ability Assessment
This article explores the foundation of ACT, Spectro-Temporal Modulation (STM), and how ACT compares to traditional speech-in-noise tests.
Read More
Loss of Auditory Nerve Fibers Uncovered in People with Tinnitus
A new study shows that individuals who report tinnitus are experiencing auditory nerve loss not picked up by conventional hearing tests.
Read More
CILcare Welcomes Experts in Auditory Science
Biotech company CILcare adds four hearing experts to its Scientific Advisory Board: Keith Darrow, Stéphane Maison, Aimo Kannt, and Dona Jayakody. The SAB will help develop CILcare’s synaptopathy pipeline, which targets early markers of neurocognitive and inflammatory diseases.
Read More
Interview with Charles Liberman, PhD 2022 La Fondation Pour l’Audition, Scientific Grand Prize Recipient
Charles Liberman, in August of 2022, lead a team of researchers at the Mass Eye and Ear, where the team was awarded a second, five-year, $12.5 million P50 Clinical Research grant to continue their research on cochlear synaptopathy.
Read More
M. Charles Liberman, PhD, Awarded La Fondation Pour l’Audition Scientific Prize
The award is reportedly one of the highest honors given in hearing science and was presented to Dr Liberman in a ceremony in Paris, France, on October 20, 2022. The Scientific Grand Prize carries a €100,000 (USD $98K) honorarium.
Read More
Mass Eye and Ear Researchers Awarded $12.5 Million NIH Grant to Continue Hidden Hearing Loss
A team of Mass Eye and Ear researchers in the Eaton-Peabody Laboratories have been awarded a five-year, $12.5 million P50 Clinical Research Center Grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) of the National Institutes of Health (NIH) to continue their research on cochlear synaptopathy, or hidden hearing loss, a type of hearing damage that was reportedly first discovered, according to an announcement from Mass Eye & Ear.
Read More
Synapse Breakdown Accelerates Age-related Hearing Loss
Gabriel Corfas, PhD, who serves as the director of Michigan Medicine’s Kresge Hearing Research Institute, says that one of the first events in “cochlear aging” that leads to hearing loss is the breakdown of synapses between inner hair cells, or IHCs, and spiral ganglion neurons, or SGNs.
Read More